Clinical Trial Update: T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases [Phase 2]

View source ↗

Summary

Phase 2 study evaluating T-cell depletion and donor hematopoietic stem cell transplantation with T-cell infusions in patients with various hematologic cancers; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Malignant Plasma Cell Neoplasms
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myelofibrosis
• Myeloproliferative Disorders
• Precancerous Conditions

Snippet

Sponsor: The Cleveland Clinic | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2017-05-30